Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding dengue pathogenesis: implications for vaccine design.

John R Stephenson1

  • 1Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical, England. john.stephenson@lshtm.ac.uk

Bulletin of the World Health Organization
|May 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human dendritic cells infected with an adenoviral vector suppress proliferation of autologous and allogeneic T cells.

Immunology·2008
Same author

Developing vaccines against flavivirus diseases: past success, present hopes and future challenges.

Novartis Foundation symposium·2007
Same author

The problem with dengue.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2005
Same author

Design and preparation of recombinant antigens as diagnostic reagents in solid-phase immunosorbent assays.

Methods in molecular medicine·2004
Same journal

Diplomatic roles of regional coordinators for WHO Member States.

Bulletin of the World Health Organization·2026
Same journal

Evaluation of an application for investments in cataract surgery, Ethiopia.

Bulletin of the World Health Organization·2026
Same journal

An umbrella protocol for the clinical evaluation of diagnostics in infectious disease.

Bulletin of the World Health Organization·2026
Same journal

Fundamental changes in regulation to improve access to biosimilars.

Bulletin of the World Health Organization·2026
Same journal

A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

Bulletin of the World Health Organization·2026
Same journal

Ebola at a critical juncture: preparedness must outpace transmission.

Bulletin of the World Health Organization·2026
See all related articles

Dengue fever affects millions globally, with severe forms causing significant illness. This review examines dengue pathogenesis and immune responses, highlighting the urgent need for safe vaccines despite safety concerns.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Dengue virus causes 50-100 million febrile illnesses annually, including severe dengue haemorrhagic fever and shock syndrome.
  • Global spread of dengue poses a significant threat to tropical populations.
  • Challenges in vaccine development include lack of models, multi-serotype protection needs, and immune response involvement in severe disease.

Purpose of the Study:

  • To review current understanding of dengue pathogenesis, focusing on the immune response.
  • To discuss concerns regarding vaccine design strategies due to immune system involvement.
  • To emphasize the urgent need for a dengue solution, potentially through vaccine evaluation.

Main Methods:

  • Review of existing literature on dengue pathogenesis and immunology.

Related Experiment Videos

  • Analysis of challenges in developing conventional and novel dengue vaccines.
  • Discussion of the role of immune responses in dengue severity and vascular damage.

    • Main Results:

    • The immune system's role in dengue pathogenesis, particularly in severe disease and vascular damage, is a key concern for vaccine development.
    • Existing vaccine strategies face hurdles related to serotype coverage and potential immunopathology.
    • Despite concerns, the acute global health situation necessitates careful evaluation of current vaccine candidates.

    Conclusions:

    • Further research into correlates of protection and pathogenesis mechanisms is crucial.
    • While disease management and vector control are important, a safe and effective dengue vaccine remains the most viable long-term solution.
    • Given the urgency, a pragmatic approach involving thorough evaluation of existing candidate vaccines is recommended to combat the escalating dengue crisis.